Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9487521 Processes and intermediates for making a JAK inhibitor

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 8, 2016

Patent Application Number

13605331

Date Filed

September 6, 2012

Patent Citations Received

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo

0

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

0

US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

0

US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders

0

US Patent 11905275 Bipyrazole derivatives as JAK inhibitors

0

Patent Primary Examiner

Patent abstract

This invention relates to processes and intermediates for making {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, useful in the treatment of diseases related to the activity of Janus kinases (JAK) including inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9487521 Processes and intermediates for making a JAK inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool